Abstract: Histiocytoid Sweet's Syndrome is a rare inflammatory disease described in 2005 as a variant of the classical Sweet's Syndrome (SS). Histopathologically, the dermal inflammatory infiltrate is composed mainly of mononuclear cells that have a histiocytic appearance and represent immature myeloid cells. We describe a case of Histiocytoid Sweet's Syndrome in an 18-year-old man. Although this patient had clinical manifestations compatible with SS, the cutaneous lesions consisted of erythematous annular plaques, which are not typical for this entity and have not been described in histiocytic form so far. The histiocytic subtype was confirmed by histopathological analysis that showed positivity for myeloperoxidase in multiple cells with histiocytic appearance.
INTRODUCTION

Sweet's syndrome (SS) is characterized by a variety of symptoms
and histological findings that include skin lesions, systemic manifestations of acute disease and a dermal inflammatory infiltrate with a significant neutrophilic component. In general, SS rapidly responds to systemic corticosteroid treatment. The disease can be divided into three groups: classical, malignancy-associated and drug-induced. 1 The classical form may be associated with infections, inflammatory bowel disease or pregnancy. 1 
Malignancy-Associates
Sweet's Syndrome is most related to acute myeloid leukemia. 2 The drug-induced variant is usually related to granulocyte-colony stimulating factor. 3 The diagnosis is based on major and minor criteria by recognizing the clinical, laboratory and histopathological findings, as well as excluding other diseases that may have similar characteristics (Chart 1).
4
CASE REPORT
An 18-year-old male patient presented with nonsuppurative tonsillitis for which he made use of dipyrone, ibuprofen and ciprofloxacin. Seven days later, oropharyngeal pain was relieved, but the patient reported high fever, chills, polyarthralgia, macroscopic hae- 
